Drug Profile
Progesterone - Merck/AbbVie
Alternative Names: PrometriumLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Schering-Plough
- Developer Merck & Co; Schering-Plough
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Amenorrhoea; Menopausal syndrome